• Home
  • About us
  • Technologies
    • Fv-Hsp72
    • Modified Annexin
  • News
  • Contact Us
Rubicon Biotechnology

Powerful biologics for trauma and cancer

info@rubiconbio.com (949) 300-8961

News

Rubiconbio News Releases

News releases related to our efforts to develop our two platform technologies are shown below.

  • June 14th, 2021 - Rubicon Awarded Ocular Cytoprotection Grant from USAMRDC
  • May 7th, 2021 - Rubicon Awarded Traumatic Brain Injury Grant from USAMRDC
  • June 15th, 2020 - Rubicon Selects Celltheon Expression Technologies for Fv-Hsp72
  • October 27th, 2017 - Rubicon Announces National Eye Institute Grant
  • September 25th, 2017 - Rubicon Announces Publication in JACC
  • January 25th, 2017 - Rubicon Signs Agreement with Foothill Scientific
  • September 16th, 2016 - Rubicon Announces Heat Shock Protein Publication

Recent News

  • June 14, 2021

    Rubicon Awarded Ocular Cytoprotection Grant from USAMRDC

    Irvine, CA - Rubicon Biotechnology LLC is pleased to announce a grant award from the…
    Read more
  • May 7, 2021

    Rubicon Awarded Traumatic Brain Injury Grant from USAMRDC

    Irvine, CA - Rubicon Biotechnology LLC is pleased to announce an award from the US…
    Read more
  • June 15, 2020

    Rubicon Selects Celltheon Expression Technologies for Fv-Hsp72

    Irvine, CA - Rubicon Biotechnology LLC is pleased to announce the selection of Celltheon Expression…
    Read more
RUBICON BIOTECHNOLOGY © 2021 All rights reserved.